Generic Name: Eculizumab
Brand Name: Soliris
Manufacturer: Alexion Pharma Canada
Indications: Hemolytic Uremic Syndrome, Atypical
Submission Type: Pre-NOC
Project Status: Complete
Date Recommendation Issued: July 18, 2013
Recommendation Type: Do not list